North America Smart Inhalers Market - Global Drivers, Opportunities, Trends, and Forecasts to 2027
The North America
smart inhalers market is expected to reach US$ 3,749.90 Mn in 2027 from US$
503.91 Mn in 2018. The market is estimated to grow with a CAGR of 25.7% from
2019-2027.
North America Smart Inhalers Market The growth of the market
is driven by the factors such as, growing geriatric population rising
prevalence of COPD and asthma, along with rising awareness regarding the
medical condition. However, the market is likely to get impacted due to risks
associated with cyber threats limited knowledge regarding the use of smart
inhalers.
North America Smart Inhalers Market The cases of asthma and
COPD has been increasing across the globe at a significant rate. During recent
years, there has been rise in the number of smokers as well as air pollution in
developed as well as developing countries. Asthma is a non-communicable disease
categorized by recurrent attacks of breathlessness and wheezing, which differ
in severity and frequency from person to person. North America Smart Inhalers
Market While an asthma attack occurs, the lining of the bronchial tubes swells,
affecting the airways to narrow, hence limiting the flow of air into and out of
the lungs. Recurrent asthma symptoms frequently lead to feeling of daytime
fatigue, sleeplessness, reduced activity levels and school and work absence. As
per estimates provided by the WHO, there are currently 235 million people
suffering from asthma across the globe. As per the Centers for Disease Control
and Prevention (CDC), the number of adults above 18 years of age currently
having asthma are approximately 19 million in the United States, accounting for
almost 7.7% of the total adult population.
📚 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝
𝐒𝐚𝐦𝐩𝐥𝐞
𝐏𝐃𝐅
𝐂𝐨𝐩𝐲@
https://www.businessmarketinsights.com/sample/TIPRE00006805
Similarly, there has been rising prevalence of COPD across
the North America. North America Smart Inhalers Market Chronic obstructive
pulmonary disease (COPD) is a progressive fatal lung disease that leads to
breathlessness, leading to predisposes then exacerbations and later causes
serious illness. As per the Global Burden of Disease Study report, a prevalence
of around 251 million cases of COPD were recorded globally during the year
2016. North America Smart Inhalers Market It is estimated that globally
approximately 3.17 million deaths were caused due to COPD during the year 2015,
accounting for almost 5% of all deaths in 2015. North America Smart Inhalers
Market The prevalence of COPD has been high in developed nations during the
recent years. For instance, COPD is recognized as the third leading cause of
death by disease in the United States. Approximately, 11 million individual are
diagnosed with COPD. Hence, the rising prevalence of respiratory conditions
such as asthma and COPD is anticipated to fuel the growth of the smart inhalers
market across the globe at an exponential rate.
US is expected to lead the market in the North America
region because the US has presence of various associations which provide help
in the field of lung diseases. For instance, American Lung Association conducts
research activities, education and training as well as undertakes initiatives
to offer better treatment and support for the patients suffering with
respiratory conditions such as asthma, COPD, influenza, lung cancer, pneumonia,
and pulmonary fibrosis among others. North America Smart Inhalers Market Therefore,
considering the above mentioned factors the growth of the market in the country
is likely to contribute largest share in the North America region during the
forecast period.
📚𝐅𝐮𝐥𝐥
𝐑𝐞𝐩𝐨𝐫𝐭
𝐋𝐢𝐧𝐤
@ https://www.businessmarketinsights.com/reports/north-america-smart-inhalers-market
𝐓𝐡𝐞 𝐋𝐢𝐬𝐭
𝐨𝐟
𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬
GlaxoSmithKline plc
Adherium Ltd.
Vectura Group plc
Novartis AG
Findair Sp. z o. o.
Cohero Health
Crux Product Design Ltd
Teva Pharmaceuticals
3M
Amiko Digital Health Limited
North America Smart Inhalers Market
North America Smart Inhalers Market The healthcare landscape
is constantly evolving with innovations that improve patient outcomes and
provide solutions for complex diseases. One such innovation is the introduction
of smart inhalers, which have revolutionized the management of respiratory
diseases. These inhalers, equipped with digital technology, have not only
improved the way patients manage chronic conditions like asthma and chronic
obstructive pulmonary disease (COPD), but they have also helped increase
medication adherence, reduce hospitalizations, and enhance overall quality of
life for individuals suffering from these diseases. In North America, smart
inhalers have become a key part of respiratory care. This article explores the
North American smart inhaler market, its drivers, trends, challenges, and the
future outlook of the industry.
Key Drivers of the Market
Several factors have contributed to the growth of the smart inhalers market
in North America:
1. Increasing
Prevalence of Respiratory Diseases
Respiratory diseases, particularly asthma and COPD, are widespread in North
America. According to the Centers for Disease Control and Prevention (CDC),
approximately 25 million people in the U.S. have asthma, and COPD is the third
leading cause of death in the country. The high prevalence of these diseases
creates a strong demand for effective management tools, including smart
inhalers.
2. Advances
in Digital Health Technology
Digital health solutions have become increasingly popular, and the adoption of
mobile health applications, telemedicine, and wearables has paved the way for
the acceptance of smart inhalers. The ability of these devices to connect to
smartphones, tablets, and cloud-based systems appeals to both patients and
healthcare providers who want more detailed insights into a patient’s condition
and treatment adherence.
𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Business Market Insights is a market research
platform that provides subscription service for industry and company reports.
Our research team has extensive professional expertise in domains such as
Electronics & Semiconductor; Aerospace & Defense; Automotive &
Transportation; Energy & Power; Healthcare; Manufacturing &
Construction; Food & Beverages; Chemicals & Materials; and Technology,
Media, & Telecommunications
You
can see this
North America Galacto Oligosaccharide Market- https://www.openpr.com/news/3925592/north-america-galacto-oligosaccharide-market-overview-top-key
North America RTD Alcoholic Beverages Market- https://www.openpr.com/news/3926211/north-america-rtd-alcoholic-beverages-market-by-key-players
North America Cancer Tissue Diagnostics Market- https://www.openpr.com/news/3925787/north-america-ceramic-balls-market-key-players-size-trends
Comments
Post a Comment